Alleviant Integrated Mental Health - Bryant
Mental health clinic in Bryant, Arkansas.

4 clinics shown
Mental health clinic in Bryant, Arkansas.
Bryant Family Clinic operates a general medical practice on West Commerce Street in Bryant, providing primary care services to patients in the area. The clinic is categorized as a medical facility offering standard outpatient care rather than specialized psychiatric or procedural mental health treatments. Patients seeking TMS therapy, esketamine, or ketamine treatments should contact the clinic directly to confirm whether these services are available or if referrals to specialty providers can be arranged.
Bryant Psychology & Behavioral Health operates a mental health practice on the I-30 Frontage Road in Bryant, serving patients in the greater Little Rock area. The practice provides outpatient mental health services, though specific treatment modalities such as TMS, ketamine, or esketamine are not detailed in available information. Patients seeking specialized interventional treatments for treatment-resistant depression should contact the clinic directly to confirm current service offerings and provider credentials.
Alleviant operates a mental health clinic in Bryant on Arkansas Highway 5, where Jason Andrews LPC provides outpatient counseling and psychotherapy services. The practice treats adults dealing with depression, anxiety, and related mental health conditions through talk therapy and medication management when clinically appropriate. Specific procedural treatments such as TMS or ketamine therapy are not detailed in available information; patients should contact the clinic to confirm current service offerings beyond standard outpatient psychiatric care.
Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.
Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.
Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.
The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.
Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.